For those who appreciate growth without the sticker shock, DOXIMITY INC-CLASS A (NYSE:DOCS) is worth considering.

Our stock screening tool has pinpointed DOXIMITY INC-CLASS A (NYSE:DOCS) as a growth stock that isn't overvalued. DOCS is excelling in various growth indicators while maintaining a solid financial footing. Furthermore, it remains attractively priced. Let's delve into the specifics below.

Assessing Growth Metrics for DOCS

ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. DOCS scores a 8 out of 10:

• DOCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.22%, which is quite impressive.
• The Earnings Per Share has been growing by 81.48% on average over the past years. This is a very strong growth
• DOCS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.46%.
• The Revenue has been growing by 40.87% on average over the past years. This is a very strong growth!
• Based on estimates for the next years, DOCS will show a very strong growth in Earnings Per Share. The EPS will grow by 20.44% on average per year.
• The Revenue is expected to grow by 15.74% on average over the next years. This is quite good.

Unpacking DOCS's Valuation Rating

ChartMill assigns a Valuation Rating to every stock. This score ranges from 0 to 10 and evaluates the different valuation aspects and compares the price to earnings and cash flows, while taking into account profitability and growth. DOCS scores a 5 out of 10:

• Based on the Price/Earnings ratio, DOCS is valued a bit cheaper than 78.38% of the companies in the same industry.
• DOCS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DOCS is cheaper than 72.97% of the companies in the same industry.
• DOCS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DOCS is cheaper than 67.57% of the companies in the same industry.
• Based on the Price/Free Cash Flow ratio, DOCS is valued a bit cheaper than 64.86% of the companies in the same industry.
• DOCS has an outstanding profitability rating, which may justify a higher PE ratio.
• A more expensive valuation may be justified as DOCS's earnings are expected to grow with 20.00% in the coming years.

Unpacking DOCS's Health Rating

Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. DOCS has achieved a 9 out of 10:

• DOCS has an Altman-Z score of 47.13. This indicates that DOCS is financially healthy and has little risk of bankruptcy at the moment.
• DOCS has a better Altman-Z score (47.13) than 100.00% of its industry peers.
• DOCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
• A Current Ratio of 8.74 indicates that DOCS has no problem at all paying its short term obligations.
• The Current ratio of DOCS (8.74) is better than 100.00% of its industry peers.
• A Quick Ratio of 8.74 indicates that DOCS has no problem at all paying its short term obligations.
• DOCS's Quick ratio of 8.74 is amongst the best of the industry. DOCS outperforms 100.00% of its industry peers.

Profitability Examination for DOCS

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, DOCS has achieved a 9:

• DOCS has a Return On Assets of 17.18%. This is amongst the best in the industry. DOCS outperforms 100.00% of its industry peers.
• DOCS has a Return On Equity of 19.53%. This is amongst the best in the industry. DOCS outperforms 100.00% of its industry peers.
• The Return On Invested Capital of DOCS (17.38%) is better than 100.00% of its industry peers.
• Measured over the past 3 years, the Average Return On Invested Capital for DOCS is above the industry average of 7.17%.
• The last Return On Invested Capital (17.38%) for DOCS is above the 3 year average (12.02%), which is a sign of increasing profitability.
• With an excellent Profit Margin value of 36.60%, DOCS belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
• DOCS's Profit Margin has improved in the last couple of years.
• DOCS has a Operating Margin of 40.58%. This is amongst the best in the industry. DOCS outperforms 100.00% of its industry peers.
• In the last couple of years the Operating Margin of DOCS has grown nicely.
• DOCS has a Gross Margin of 90.19%. This is amongst the best in the industry. DOCS outperforms 97.30% of its industry peers.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Check the latest full fundamental report of DOCS for a complete fundamental analysis.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.